Mikael Dolsten

Insider · Director · A

Mikael Dolsten files insider transactions with the SEC as a director of Agilent Technologies. We hold 2 disclosed purchases and sales filed since 18 June 2008, 1 of them in the last 90 days.

Files for 6 companiesA, RCKT, APLS, PFE and 2 more
Disclosed buys and sells2 in all, 1 in the last 90 days
Last disclosure9 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 22 September 2021 — 4 September 2026Director · Agilent Technologies 10 Form 4 lines · source: SEC Form 4
Filed 9 September 2024 — 18 June 2026Director · Rocket Pharmaceuticals 6 Form 4 lines · source: SEC Form 4
Filed 27 February 2026 — 14 May 2026Director · Apellis Pharmaceuticals 7 Form 4 lines · source: SEC Form 4
Filed 30 October 2009 — 12 September 2024President R&D · Pfizer 240 Form 4 lines · source: SEC Form 4
Filed 31 March 2015 — 21 May 2021Director · Karyopharm Therapeutics 8 Form 4 lines · source: SEC Form 4
Filed 16 June 2008 — 15 October 2009Sr. VP & Pres., Wyeth Research · Wyeth 2 Form 4 lines · source: SEC Form 4

Every transaction

273 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing

Sort byOpen-market trades only273 of 273 shown


4 Sep 2026	9 Sep 2026SEC Form 4	5 d	sold on the open market	Agilent Technologies	634 shares	down −4.1%	up +0.0%
18 Jun 2026	6 Jul 2026SEC Form 4	18 d	was grantednot a trade	Rocket Pharmaceuticals	22,862 shares	up +8.4%	down −9.0%
18 Jun 2026	6 Jul 2026SEC Form 4	18 d	was grantednot a trade	Rocket Pharmaceuticalsderivative	64,860 shares	up +8.4%	down −9.0%
29 May 2026	2 Jun 2026SEC Form 4	4 d	sold on the open market	Agilent Technologies	1,600 shares	up +6.8%	up +7.2%
14 May 2026	14 May 2026SEC Form 4	0 d	disposed of in a tender offernot a trade	APLSApellis Pharmaceuticals	14,312 shares	—	—
14 May 2026	14 May 2026SEC Form 4	0 d	returned to the issuernot a trade	APLSApellis Pharmaceuticals	14,312 shares	—	—
14 May 2026	14 May 2026SEC Form 4	0 d	returned to the issuernot a trade	APLSApellis Pharmaceuticalsderivative	24,135 shares	—	—
19 Mar 2026	23 Mar 2026SEC Form 4	4 d	was grantednot a trade	Agilent Technologies	2,158 shares	up +29.5%	up +29.2%
19 Mar 2026	23 Mar 2026SEC Form 4	4 d	was grantednot a trade	Agilent Technologies	2,158 shares	up +29.5%	up +29.2%
27 Feb 2026	3 Mar 2026SEC Form 4	4 d	was grantednot a trade	APLSApellis Pharmaceuticals	14,312 shares	—	—
27 Feb 2026	3 Mar 2026SEC Form 4	4 d	was grantednot a trade	APLSApellis Pharmaceuticalsderivative	24,135 shares	—	—
27 Feb 2026	3 Mar 2026SEC Form 4	4 d	was grantednot a trade	APLSApellis Pharmaceuticalsderivative	24,135 shares	—	—
27 Feb 2026	3 Mar 2026SEC Form 4	4 d	was grantednot a trade	APLSApellis Pharmaceuticals	14,312 shares	—	—
1 Dec 2025	3 Dec 2025SEC Form 4	2 d	sold on the open market	Agilent Technologies	2,600 shares	down −3.6%	down −3.0%
18 Jun 2025	18 Jul 2025SEC Form 4	30 d	was grantednot a trade	Rocket Pharmaceuticals	30,000 shares	up +28.3%	up +19.4%
14 Mar 2025	18 Mar 2025SEC Form 4	4 d	was grantednot a trade	Agilent Technologies	1,819 shares	up +19.5%	up +17.6%
5 Mar 2025	24 Apr 2025SEC Form 4	50 d	acquired or disposed of, othernot a trade	Rocket Pharmaceuticals	14,220 shares	down −60.6%	down −51.1%
12 Sep 2024	16 Sep 2024SEC Form 4	4 d	returned to the issuernot a trade	Pfizerderivative	137,760 shares	down −4.7%	down −7.6%
12 Sep 2024	16 Sep 2024SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	137,760 shares	down −4.7%	down −7.6%
12 Sep 2024	16 Sep 2024SEC Form 4	4 d	returned to the issuernot a trade	Pfizerderivative	126,794 shares	down −4.7%	down −7.6%
12 Sep 2024	16 Sep 2024SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	126,794 shares	down −4.7%	down −7.6%
9 Sep 2024	11 Sep 2024SEC Form 4	2 d	was grantednot a trade	Rocket Pharmaceuticalsderivative	27,545 shares	down −81.6%	down −80.9%
9 Sep 2024	11 Sep 2024SEC Form 4	2 d	was grantednot a trade	Rocket Pharmaceuticalsderivative	22,988 shares	down −81.6%	down −80.9%
15 Mar 2024	19 Mar 2024SEC Form 4	4 d	was grantednot a trade	Agilent Technologies	1,678 shares	down −1.9%	down −1.8%
28 Feb 2024	29 Feb 2024SEC Form 4	1 d	had shares withheld for taxnot a trade	Pfizer	21,437 shares	up +2.7%	up +4.6%
27 Feb 2024	28 Feb 2024SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	214,880 shares	up +3.3%	up +2.7%
27 Feb 2024	28 Feb 2024SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	189,867 shares	up +3.3%	up +2.7%
23 Feb 2024	27 Feb 2024SEC Form 4	4 d	had shares withheld for taxnot a trade	Pfizer	24,822 shares	up +0.1%	up +3.3%
15 Dec 2023	19 Dec 2023SEC Form 4	4 d	recorded a discretionary transactionnot a trade	Pfizerderivative	37,552 shares	up +4.3%	down −1.3%
16 Mar 2023	20 Mar 2023SEC Form 4	4 d	was grantednot a trade	Agilent Technologies	1,658 shares	up +5.8%	up +7.6%
25 Feb 2023	28 Feb 2023SEC Form 4	3 d	had shares withheld for taxnot a trade	Pfizer	37,078 shares	down −33.5%	down −31.5%
23 Feb 2023	24 Feb 2023SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	137,760 shares	down −34.3%	down −33.5%
23 Feb 2023	24 Feb 2023SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	119,894 shares	down −34.3%	down −33.5%
22 Feb 2023	24 Feb 2023SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	32,592 shares	down −34.5%	down −33.5%
7 Nov 2022	9 Nov 2022SEC Form 4	2 d	exercised options overnot a trade	Pfizerderivative	127,146 shares	down −41.0%	down −40.5%
7 Nov 2022	9 Nov 2022SEC Form 4	2 d	exercised options overnot a trade	Pfizerderivative	133,430 shares	down −41.0%	down −40.5%
7 Nov 2022	9 Nov 2022SEC Form 4	2 d	exercised options overnot a trade	Pfizer	50,938 shares	down −41.0%	down −40.5%
7 Nov 2022	9 Nov 2022SEC Form 4	2 d	exercised options overnot a trade	Pfizer	28,170 shares	down −41.0%	down −40.5%
11 May 2022	12 May 2022SEC Form 4	1 d	recorded a discretionary transactionnot a trade	Pfizerderivative	15,167 shares	down −43.8%	down −44.9%
11 May 2022	12 May 2022SEC Form 4	1 d	sold on the open market	Pfizer	200 shares	down −43.8%	down −44.9%
11 May 2022	12 May 2022SEC Form 4	1 d	sold on the open market	Pfizer	2,358 shares	down −43.8%	down −44.9%
11 May 2022	12 May 2022SEC Form 4	1 d	sold on the open market	Pfizer	2,891 shares	down −43.8%	down −44.9%
11 May 2022	12 May 2022SEC Form 4	1 d	sold on the open market	Pfizer	7,876 shares	down −43.8%	down −44.9%
11 May 2022	12 May 2022SEC Form 4	1 d	sold on the open market	Pfizer	18,562 shares	down −43.8%	down −44.9%
11 May 2022	12 May 2022SEC Form 4	1 d	sold on the open market	Pfizer	32,015 shares	down −43.8%	down −44.9%
17 Mar 2022	21 Mar 2022SEC Form 4	4 d	was grantednot a trade	Agilent Technologies	1,785 shares	up +5.8%	up +4.8%
3 Mar 2022	4 Mar 2022SEC Form 4	1 d	exercised options overnot a trade	Pfizerderivative	127,674 shares	down −41.9%	down −42.9%
3 Mar 2022	4 Mar 2022SEC Form 4	1 d	exercised options overnot a trade	Pfizerderivative	158,331 shares	down −41.9%	down −42.9%
3 Mar 2022	4 Mar 2022SEC Form 4	1 d	exercised options overnot a trade	Pfizer	62,022 shares	down −41.9%	down −42.9%
3 Mar 2022	4 Mar 2022SEC Form 4	1 d	exercised options overnot a trade	Pfizer	40,438 shares	down −41.9%	down −42.9%
26 Feb 2022	1 Mar 2022SEC Form 4	3 d	had shares withheld for taxnot a trade	Pfizer	29,744 shares	down −41.8%	down −39.3%
24 Feb 2022	25 Feb 2022SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	126,794 shares	down −39.6%	down −41.8%
24 Feb 2022	25 Feb 2022SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	111,516 shares	down −39.6%	down −41.8%
23 Feb 2022	25 Feb 2022SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	29,767 shares	down −40.7%	down −41.8%
17 Dec 2021	21 Dec 2021SEC Form 4	4 d	recorded a discretionary transactionnot a trade	Pfizerderivative	25,219 shares	down −53.3%	down −52.9%
17 Dec 2021	21 Dec 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	152,085 shares	down −53.3%	down −52.9%
17 Dec 2021	21 Dec 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizer	71,187 shares	down −53.3%	down −52.9%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	recorded a discretionary transactionnot a trade	Pfizerderivative	47,828 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	153,789 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	145,970 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	127,160 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizer	76,135 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizer	64,841 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	exercised options overnot a trade	Pfizer	58,572 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	2,124 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	2,301 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	3,197 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	3,396 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	5,227 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	6,708 shares	down −44.6%	down −44.0%
11 Nov 2021	15 Nov 2021SEC Form 4	4 d	sold on the open market	Pfizer	36,711 shares	down −44.6%	down −44.0%
22 Sep 2021	23 Sep 2021SEC Form 4	1 d	was grantednot a trade	Agilent Technologies	567 shares	down −16.1%	down −16.2%
21 May 2021	21 May 2021SEC Form 4	0 d	was grantednot a trade	Karyopharm Therapeuticsderivative	23,900 shares	down −98.8%	down −98.8%
27 Feb 2021	2 Mar 2021SEC Form 4	3 d	had shares withheld for taxnot a trade	Pfizer	23,841 shares	down −17.0%	down −17.1%
25 Feb 2021	2 Mar 2021SEC Form 4	5 d	had shares withheld for taxnot a trade	Pfizer	28,271 shares	down −17.9%	down −17.1%
25 Feb 2021	1 Mar 2021SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	210,697 shares	down −17.9%	down −17.5%
25 Feb 2021	1 Mar 2021SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	182,050 shares	down −17.9%	down −17.5%
25 Feb 2021	1 Mar 2021SEC Form 4	4 d	had shares withheld for taxnot a trade	Pfizer	28,271 shares	down −17.9%	down −17.5%
21 May 2020	26 May 2020SEC Form 4	5 d	was grantednot a trade	Karyopharm Therapeuticsderivative	16,400 shares	down −99.4%	down −99.4%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	500 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	5,517 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	6,470 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	9,700 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	14,727 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	16,840 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	17,357 shares	down −23.1%	down −22.3%
18 May 2020	19 May 2020SEC Form 4	1 d	sold on the open market	Pfizer	24,242 shares	down −23.1%	down −22.3%
28 Feb 2020	3 Mar 2020SEC Form 4	4 d	had shares withheld for taxnot a trade	Pfizer	39,446 shares	down −12.4%	down −14.6%
27 Feb 2020	28 Feb 2020SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	212,961 shares	down −14.1%	down −12.4%
27 Feb 2020	28 Feb 2020SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	182,461 shares	down −14.1%	down −12.4%
26 Feb 2020	28 Feb 2020SEC Form 4	2 d	was grantednot a trade	Pfizer	45,566 shares	down −15.7%	down −12.4%
26 Feb 2020	28 Feb 2020SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	15,478 shares	down −15.7%	down −12.4%
26 Feb 2020	28 Feb 2020SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	22,314 shares	down −15.7%	down −12.4%
6 Jun 2019	7 Jun 2019SEC Form 4	1 d	was grantednot a trade	Karyopharm Therapeuticsderivative	25,000 shares	down −97.9%	down −98.0%
4 Mar 2019	5 Mar 2019SEC Form 4	1 d	sold on the open market	Pfizer	2,187 shares	down −32.0%	down −31.7%
4 Mar 2019	5 Mar 2019SEC Form 4	1 d	sold on the open market	Pfizer	2,400 shares	down −32.0%	down −31.7%
4 Mar 2019	5 Mar 2019SEC Form 4	1 d	sold on the open market	Pfizer	2,600 shares	down −32.0%	down −31.7%
4 Mar 2019	5 Mar 2019SEC Form 4	1 d	sold on the open market	Pfizer	3,250 shares	down −32.0%	down −31.7%
4 Mar 2019	5 Mar 2019SEC Form 4	1 d	sold on the open market	Pfizer	38,645 shares	down −32.0%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	155,172 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	126,366 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	exercised options overnot a trade	Pfizer	57,609 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	exercised options overnot a trade	Pfizer	48,582 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	sold on the open market	Pfizer	2,300 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	sold on the open market	Pfizer	5,927 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	sold on the open market	Pfizer	14,760 shares	down −32.5%	down −31.7%
1 Mar 2019	5 Mar 2019SEC Form 4	4 d	sold on the open market	Pfizer	77,484 shares	down −32.5%	down −31.7%
28 Feb 2019	1 Mar 2019SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	150,419 shares	down −32.5%	down −32.5%
28 Feb 2019	1 Mar 2019SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	126,762 shares	down −32.5%	down −32.5%
27 Feb 2019	1 Mar 2019SEC Form 4	2 d	was grantednot a trade	Pfizer	96,183 shares	down −31.8%	down −32.5%
27 Feb 2019	1 Mar 2019SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	26,672 shares	down −31.8%	down −32.5%
27 Feb 2019	1 Mar 2019SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	47,101 shares	down −31.8%	down −32.5%
23 Feb 2019	26 Feb 2019SEC Form 4	3 d	had shares withheld for taxnot a trade	Pfizer	54,568 shares	down −31.8%	down −31.9%
31 Jan 2019	1 Feb 2019SEC Form 4	1 d	exercised options overnot a trade	Pfizerderivative	144,928 shares	down −31.0%	down −31.7%
31 Jan 2019	1 Feb 2019SEC Form 4	1 d	exercised options overnot a trade	Pfizerderivative	164,534 shares	down −31.0%	down −31.7%
31 Jan 2019	1 Feb 2019SEC Form 4	1 d	exercised options overnot a trade	Pfizer	83,907 shares	down −31.0%	down −31.7%
31 Jan 2019	1 Feb 2019SEC Form 4	1 d	exercised options overnot a trade	Pfizer	42,061 shares	down −31.0%	down −31.7%
13 Sep 2018	17 Sep 2018SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	185,185 shares	down −31.7%	down −31.9%
13 Sep 2018	17 Sep 2018SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	158,662 shares	down −31.7%	down −31.9%
13 Sep 2018	17 Sep 2018SEC Form 4	4 d	exercised options overnot a trade	Pfizer	124,501 shares	down −31.7%	down −31.9%
13 Sep 2018	17 Sep 2018SEC Form 4	4 d	exercised options overnot a trade	Pfizer	57,211 shares	down −31.7%	down −31.9%
13 Aug 2018	14 Aug 2018SEC Form 4	1 d	recorded a discretionary transactionnot a trade	Pfizerderivative	24,504 shares	down −28.3%	down −28.1%
19 Jun 2018	20 Jun 2018SEC Form 4	1 d	was grantednot a trade	Karyopharm Therapeuticsderivative	17,000 shares	down −99.4%	down −99.4%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	100 shares	down −20.4%	down −20.0%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	2,329 shares	down −20.4%	down −20.0%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	4,154 shares	down −20.4%	down −20.0%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	5,300 shares	down −20.4%	down −20.0%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	9,900 shares	down −20.4%	down −20.0%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	15,459 shares	down −20.4%	down −20.0%
9 Mar 2018	12 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	32,457 shares	down −20.4%	down −20.0%
2 Mar 2018	5 Mar 2018SEC Form 4	3 d	sold on the open market	Pfizer	13,986 shares	down −18.6%	down −18.9%
28 Feb 2018	2 Mar 2018SEC Form 4	2 d	exercised options overnot a trade	Pfizer	198,238 shares	down −19.4%	down −18.6%
28 Feb 2018	2 Mar 2018SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	38,152 shares	down −19.4%	down −18.6%
28 Feb 2018	2 Mar 2018SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	120,330 shares	down −19.4%	down −18.6%
28 Feb 2018	2 Mar 2018SEC Form 4	2 d	exercised options overnot a trade	Pfizerderivative	198,238 shares	down −19.4%	down −18.6%
27 Feb 2018	28 Feb 2018SEC Form 4	1 d	sold on the open market	Pfizer	100 shares	down −20.4%	down −19.4%
27 Feb 2018	28 Feb 2018SEC Form 4	1 d	sold on the open market	Pfizer	100 shares	down −20.4%	down −19.4%
27 Feb 2018	28 Feb 2018SEC Form 4	1 d	sold on the open market	Pfizer	7,844 shares	down −20.4%	down −19.4%
27 Feb 2018	28 Feb 2018SEC Form 4	1 d	sold on the open market	Pfizer	9,132 shares	down −20.4%	down −19.4%
27 Feb 2018	28 Feb 2018SEC Form 4	1 d	sold on the open market	Pfizer	22,291 shares	down −20.4%	down −19.4%
27 Feb 2018	28 Feb 2018SEC Form 4	1 d	sold on the open market	Pfizer	25,120 shares	down −20.4%	down −19.4%
26 Feb 2018	28 Feb 2018SEC Form 4	2 d	was grantednot a trade	Pfizer	86,086 shares	down −21.1%	down −19.4%
26 Feb 2018	28 Feb 2018SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	42,157 shares	down −21.1%	down −19.4%
24 Feb 2018	27 Feb 2018SEC Form 4	3 d	exercised options overnot a trade	Pfizerderivative	174,081 shares	down −19.2%	down −20.4%
24 Feb 2018	27 Feb 2018SEC Form 4	3 d	exercised options overnot a trade	Pfizer	174,081 shares	down −19.2%	down −20.4%
24 Feb 2018	27 Feb 2018SEC Form 4	3 d	had shares withheld for taxnot a trade	Pfizer	53,949 shares	down −19.2%	down −20.4%
24 Feb 2018	27 Feb 2018SEC Form 4	3 d	had shares withheld for taxnot a trade	Pfizer	55,544 shares	down −19.2%	down −20.4%
23 Feb 2018	27 Feb 2018SEC Form 4	4 d	recorded a discretionary transactionnot a trade	Pfizerderivative	16,547 shares	down −19.2%	down −20.4%
22 Feb 2018	23 Feb 2018SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	144,485 shares	down −18.1%	down −19.2%
22 Feb 2018	23 Feb 2018SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	120,792 shares	down −18.1%	down −19.2%
16 Jun 2017	19 Jun 2017SEC Form 4	3 d	recorded a discretionary transactionnot a trade	Pfizerderivative	16,682 shares	down −11.2%	down −11.9%
15 Jun 2017	16 Jun 2017SEC Form 4	1 d	was grantednot a trade	Karyopharm Therapeuticsderivative	17,000 shares	down −98.8%	down −98.8%
2 Mar 2017	3 Mar 2017SEC Form 4	1 d	sold on the open market	Pfizer	15,401 shares	down −15.2%	down −15.2%
1 Mar 2017	3 Mar 2017SEC Form 4	2 d	sold on the open market	Pfizer	15,569 shares	down −14.9%	down −15.2%
27 Feb 2017	1 Mar 2017SEC Form 4	2 d	was grantednot a trade	Pfizer	31,800 shares	down −14.6%	down −14.9%
27 Feb 2017	1 Mar 2017SEC Form 4	2 d	sold on the open market	Pfizer	6,655 shares	down −14.6%	down −14.9%
27 Feb 2017	1 Mar 2017SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	16,400 shares	down −14.6%	down −14.9%
27 Feb 2017	1 Mar 2017SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	16,581 shares	down −14.6%	down −14.9%
27 Feb 2017	1 Mar 2017SEC Form 4	2 d	sold on the open market	Pfizer	24,668 shares	down −14.6%	down −14.9%
27 Feb 2017	1 Mar 2017SEC Form 4	2 d	sold on the open market	Pfizer	27,523 shares	down −14.6%	down −14.9%
23 Feb 2017	27 Feb 2017SEC Form 4	4 d	exercised options overnot a trade	Pfizer	218,447 shares	down −14.0%	down −14.6%
23 Feb 2017	27 Feb 2017SEC Form 4	4 d	had shares withheld for taxnot a trade	Pfizer	53,839 shares	down −14.0%	down −14.6%
23 Feb 2017	27 Feb 2017SEC Form 4	4 d	had shares withheld for taxnot a trade	Pfizer	105,761 shares	down −14.0%	down −14.6%
23 Feb 2017	27 Feb 2017SEC Form 4	4 d	exercised options overnot a trade	Pfizerderivative	218,447 shares	down −14.0%	down −14.6%
23 Feb 2017	27 Feb 2017SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	146,104 shares	down −14.0%	down −14.6%
23 Feb 2017	27 Feb 2017SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	121,294 shares	down −14.0%	down −14.6%
14 Nov 2016	16 Nov 2016SEC Form 4	2 d	recorded a discretionary transactionnot a trade	Pfizerderivative	149,747 shares	down −9.6%	down −8.4%
16 Jun 2016	17 Jun 2016SEC Form 4	1 d	was grantednot a trade	Karyopharm Therapeuticsderivative	10,000 shares	down −98.6%	down −98.5%
4 May 2016	5 May 2016SEC Form 4	1 d	sold on the open market	Pfizer	100 shares	down −12.3%	down −12.8%
4 May 2016	5 May 2016SEC Form 4	1 d	sold on the open market	Pfizer	153 shares	down −12.3%	down −12.8%
4 May 2016	5 May 2016SEC Form 4	1 d	sold on the open market	Pfizer	9,900 shares	down −12.3%	down −12.8%
4 May 2016	5 May 2016SEC Form 4	1 d	sold on the open market	Pfizer	14,000 shares	down −12.3%	down −12.8%
4 May 2016	5 May 2016SEC Form 4	1 d	sold on the open market	Pfizer	15,000 shares	down −12.3%	down −12.8%
4 May 2016	5 May 2016SEC Form 4	1 d	sold on the open market	Pfizer	28,435 shares	down −12.3%	down −12.8%
28 Feb 2016	1 Mar 2016SEC Form 4	2 d	was grantednot a trade	Pfizer	18,530 shares	down −3.1%	down −2.5%
28 Feb 2016	1 Mar 2016SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	9,549 shares	down −3.1%	down −2.5%
25 Feb 2016	26 Feb 2016SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	155,172 shares	down −4.3%	down −3.1%
25 Feb 2016	26 Feb 2016SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	138,675 shares	down −4.3%	down −3.1%
24 Feb 2016	26 Feb 2016SEC Form 4	2 d	exercised options overnot a trade	Pfizer	210,280 shares	down −2.5%	down −3.1%
24 Feb 2016	26 Feb 2016SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	52,450 shares	down −2.5%	down −3.1%
24 Feb 2016	26 Feb 2016SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	99,223 shares	down −2.5%	down −3.1%
24 Feb 2016	26 Feb 2016SEC Form 4	2 d	exercised options overnot a trade	Pfizerderivative	210,280 shares	down −2.5%	down −3.1%
22 May 2015	26 May 2015SEC Form 4	4 d	was grantednot a trade	Karyopharm Therapeuticsderivative	10,000 shares	down −99.6%	down −99.6%
31 Mar 2015	2 Apr 2015SEC Form 4	2 d	was grantednot a trade	Karyopharm Therapeuticsderivative	20,000 shares	down −99.6%	down −99.6%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	400 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	1,200 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	2,000 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	2,400 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	2,500 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	3,000 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	3,659 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	4,500 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	7,939 shares	down −15.1%	down −13.8%
5 Mar 2015	6 Mar 2015SEC Form 4	1 d	sold on the open market	Pfizer	30,700 shares	down −15.1%	down −13.8%
26 Feb 2015	27 Feb 2015SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	144,928 shares	down −15.4%	down −14.7%
26 Feb 2015	27 Feb 2015SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	120,805 shares	down −15.4%	down −14.7%
25 Feb 2015	27 Feb 2015SEC Form 4	2 d	exercised options overnot a trade	Pfizer	146,396 shares	down −15.5%	down −14.7%
25 Feb 2015	27 Feb 2015SEC Form 4	2 d	was grantednot a trade	Pfizer	23,006 shares	down −15.5%	down −14.7%
25 Feb 2015	27 Feb 2015SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	8,497 shares	down −15.5%	down −14.7%
25 Feb 2015	27 Feb 2015SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	44,915 shares	down −15.5%	down −14.7%
25 Feb 2015	27 Feb 2015SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	57,692 shares	down −15.5%	down −14.7%
25 Feb 2015	27 Feb 2015SEC Form 4	2 d	exercised options overnot a trade	Pfizerderivative	146,396 shares	down −15.5%	down −14.7%
13 Jan 2015	15 Jan 2015SEC Form 4	2 d	was grantednot a trade	Pfizerderivative	410 shares	down −9.7%	down −9.6%
10 Oct 2014	14 Oct 2014SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	458 shares	up +0.5%	up +2.9%
11 Jul 2014	15 Jul 2014SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	443 shares	down −2.6%	down −3.7%
31 Mar 2014	2 Apr 2014SEC Form 4	2 d	was grantednot a trade	Pfizerderivative	67 shares	down −8.8%	down −9.3%
14 Mar 2014	18 Mar 2014SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	1,903 shares	down −6.2%	down −8.3%
4 Mar 2014	5 Mar 2014SEC Form 4	1 d	sold on the open market	Pfizer	7,700 shares	down −10.4%	down −10.6%
4 Mar 2014	5 Mar 2014SEC Form 4	1 d	sold on the open market	Pfizer	28,089 shares	down −10.4%	down −10.6%
27 Feb 2014	28 Feb 2014SEC Form 4	1 d	was grantednot a trade	Pfizer	28,915 shares	down −9.2%	down −8.8%
27 Feb 2014	28 Feb 2014SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	158,662 shares	down −9.2%	down −8.8%
27 Feb 2014	28 Feb 2014SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	126,366 shares	down −9.2%	down −8.8%
26 Feb 2014	28 Feb 2014SEC Form 4	2 d	was grantednot a trade	Pfizer	64,581 shares	down −8.5%	down −8.8%
26 Feb 2014	28 Feb 2014SEC Form 4	2 d	had shares withheld for taxnot a trade	Pfizer	28,792 shares	down −8.5%	down −8.8%
31 Dec 2013	2 Jan 2014SEC Form 4	2 d	was grantednot a trade	Pfizerderivative	70 shares	down −4.4%	down −3.9%
13 Dec 2013	16 Dec 2013SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	72 shares	down −3.2%	down −3.2%
27 Nov 2013	2 Dec 2013SEC Form 4	5 d	was grantednot a trade	Pfizerderivative	68 shares	down −8.2%	down −8.0%
15 Nov 2013	18 Nov 2013SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	139 shares	down −9.1%	down −8.5%
31 Oct 2013	4 Nov 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	68 shares	down −4.6%	down −6.3%
15 Oct 2013	16 Oct 2013SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	77 shares	up +0.4%	down −1.7%
30 Sep 2013	2 Oct 2013SEC Form 4	2 d	was grantednot a trade	Pfizerderivative	72 shares	up +1.9%	up +0.9%
13 Sep 2013	17 Sep 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	76 shares	up +2.7%	up +2.2%
30 Aug 2013	4 Sep 2013SEC Form 4	5 d	was grantednot a trade	Pfizerderivative	78 shares	up +3.8%	up +3.2%
15 Aug 2013	16 Aug 2013SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	76 shares	up +1.7%	up +3.2%
31 Jul 2013	1 Aug 2013SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	111 shares	up +0.2%	up +0.6%
15 Jul 2013	16 Jul 2013SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	75 shares	up +1.7%	up +2.1%
28 Jun 2013	2 Jul 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	78 shares	up +4.5%	up +5.7%
14 Jun 2013	18 Jun 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	73 shares	up +0.7%	down −0.4%
31 May 2013	3 Jun 2013SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	82 shares	up +7.5%	up +5.5%
15 May 2013	16 May 2013SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	107 shares	down −0.9%	up +0.1%
30 Apr 2013	1 May 2013SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	75 shares	up +0.7%	up +1.3%
15 Apr 2013	17 Apr 2013SEC Form 4	2 d	was grantednot a trade	Pfizerderivative	71 shares	down −3.8%	down −5.2%
28 Mar 2013	1 Apr 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	73 shares	up +1.5%	up +1.5%
15 Mar 2013	18 Mar 2013SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	2,132 shares	up +4.5%	up +4.4%
6 Mar 2013	8 Mar 2013SEC Form 4	2 d	sold on the open market	Pfizer	13,781 shares	up +4.1%	up +3.9%
6 Mar 2013	8 Mar 2013SEC Form 4	2 d	sold on the open market	Pfizer	16,801 shares	up +4.1%	up +3.9%
28 Feb 2013	4 Mar 2013SEC Form 4	4 d	was grantednot a trade	Pfizer	63,147 shares	up +7.0%	up +5.7%
28 Feb 2013	4 Mar 2013SEC Form 4	4 d	was grantednot a trade	Pfizer	33,532 shares	up +7.0%	up +5.7%
28 Feb 2013	4 Mar 2013SEC Form 4	4 d	had shares withheld for taxnot a trade	Pfizer	32,565 shares	up +7.0%	up +5.7%
28 Feb 2013	4 Mar 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	78 shares	up +7.0%	up +5.7%
28 Feb 2013	4 Mar 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	198,238 shares	up +7.0%	up +5.7%
28 Feb 2013	4 Mar 2013SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	164,534 shares	up +7.0%	up +5.7%
28 Dec 2012	2 Jan 2013SEC Form 4	5 d	was grantednot a trade	Pfizerderivative	86 shares	up +17.6%	up +13.0%
14 Dec 2012	17 Dec 2012SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	83 shares	up +16.3%	up +15.5%
30 Nov 2012	3 Dec 2012SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	84 shares	up +17.0%	up +16.7%
15 Nov 2012	19 Nov 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	102 shares	up +23.8%	up +21.3%
31 Oct 2012	1 Nov 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	85 shares	up +17.7%	up +19.3%
15 Oct 2012	16 Oct 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	83 shares	up +14.5%	up +13.5%
28 Sep 2012	1 Oct 2012SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	85 shares	up +17.8%	up +16.9%
14 Sep 2012	18 Sep 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	89 shares	up +23.0%	up +21.9%
31 Aug 2012	4 Sep 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	89 shares	up +22.7%	up +23.1%
15 Aug 2012	16 Aug 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	95 shares	up +21.8%	up +21.9%
31 Jul 2012	1 Aug 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	88 shares	up +21.8%	up +22.3%
13 Jul 2012	17 Jul 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	93 shares	up +28.4%	up +24.0%
29 Jun 2012	3 Jul 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	92 shares	up +27.3%	up +28.0%
15 Jun 2012	19 Jun 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	94 shares	up +29.5%	up +28.9%
31 May 2012	1 Jun 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	97 shares	up +33.9%	up +35.3%
15 May 2012	16 May 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	97 shares	up +31.3%	up +29.3%
30 Apr 2012	1 May 2012SEC Form 4	1 d	was grantednot a trade	Pfizerderivative	93 shares	up +27.9%	up +28.5%
13 Apr 2012	16 Apr 2012SEC Form 4	3 d	was grantednot a trade	Pfizerderivative	97 shares	up +34.0%	up +33.2%
30 Mar 2012	3 Apr 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	49 shares	up +29.3%	up +29.9%
23 Feb 2012	27 Feb 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	218,447 shares	up +39.2%	up +37.7%
23 Feb 2012	27 Feb 2012SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	185,185 shares	up +39.2%	up +37.7%
23 Feb 2012	27 Feb 2012SEC Form 4	4 d	was grantednot a trade	Pfizer	42,413 shares	up +39.2%	up +37.7%
24 Feb 2011	28 Feb 2011SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	210,280 shares	up +54.9%	up +52.2%
24 Feb 2011	28 Feb 2011SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	174,081 shares	up +54.9%	up +52.2%
24 Feb 2011	28 Feb 2011SEC Form 4	4 d	was grantednot a trade	Pfizer	68,290 shares	up +54.9%	up +52.2%
25 Feb 2010	1 Mar 2010SEC Form 4	4 d	was grantednot a trade	Pfizerderivative	146,396 shares	up +65.5%	up +65.0%
25 Feb 2010	1 Mar 2010SEC Form 4	4 d	was grantednot a trade	Pfizer	36,212 shares	up +65.5%	up +65.0%
30 Oct 2009	3 Nov 2009SEC Form 4	4 d	was grantednot a trade	Pfizer	58,720 shares	up +71.9%	up +73.4%
30 Oct 2009	3 Nov 2009SEC Form 4	4 d	was grantednot a trade	Pfizer	41,104 shares	up +71.9%	up +73.4%
15 Oct 2009	19 Oct 2009SEC Form 4	4 d	returned to the issuernot a trade	WYEWyethderivative	52,000 shares	—	—
16 Jun 2008	18 Jun 2008SEC Form 4	2 d	was grantednot a trade	WYEWyethderivative	52,000 shares	—	—

Both percentages are the stock’s move, not Mikael Dolsten’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 264 of the 273 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.